Scilex Holding

Scilex Holding Company is committed to the development and commercialization of non-opioid pain management products. We are firmly dedicated to becoming a global leader in pain management, adhering to social, environmental, economic, and ethical principles, and responsibly developing pharmaceuticals to maximize quality of life. Scilex Holding has received FDA approval for two non-opioid pain relief products, GLOPERBA and ELYXYB™, for the treatment of gout in adults, as well as an oral solution for the acute treatment of migraine in adults.